All Submissions
Use of an SGLT2 Inhibitor is associated with weight loss and improved glycaemia: data from a diabetes centre in the UAE
0 views
0 downloads
Video
PDF
Abstract
0 Datasets
Powered by
Discover more research and events on
morressier.com
Imprint
Terms of Service
Privacy Policy
Accessibility